Loading Page
Dr. Austin Michael Oberlin, MD is an obstetrician and gynecologist in Cortlandt Manor, NY specializing in obstetrics & gynecology. He graduated from Virginia Commonwealth University (VCU) School of Medicine in 2019 and has 7 years of experience. Dr. Austin Michael Oberlin, MD is affiliated with Yale Medicine, Yale University and Yale New Haven Health.
Dr. Austin Michael Oberlin, MD graduated from Virginia Commonwealth University (VCU) School of Medicine in 2019. He completed residency at New York-Presbyterian Hospital. He has a state license in New York.
Medical School: Virginia Commonwealth University (VCU) School of Medicine (2019)
Residency: New York-Presbyterian Hospital
Licensed In: New York
Dr. Austin Michael Oberlin, MD is associated with these hospitals and organizations:
Dr. Austin Michael Oberlin, MD appears to accept the following insurance providers: CorVel, Great-West Healthcare, WellCare, MultiPlan, Community Care Network (CCN), United Healthcare, Aetna, Oxford Health Plans, Medicare, Consumer Health Network, Medicaid, Humana, Cigna, Anthem, ConnectiCare, Focus Health Solutions, Prime Health, First Health, Private Healthcare Systems (PHCS), TRICARE - HEALTH NET FEDERAL, COMPWORKS, HEALTHCARE VALUE MANAGEMENT, MANAGED COMP, TRICARE/CHAMPUS, HUSKY and PREFERRED HEALTH WORKS.
According to our sources, Dr. Austin Michael Oberlin, MD accepts the following insurance providers:
Dr. Austin Michael Oberlin, MD does not have any reviews yet, be the first to leave a review of Dr. Austin Michael Oberlin, MD here: Leave a Review
Dr. Austin Oberlin's area of specialization is obstetrics & gynecology. He graduated from Virginia Commonwealth University (VCU) School of Medicine. Dr. Oberlin's training includes a residency program at New York-Presbyterian Hospital. He appears to be in-network for Anthem, ConnectiCare, and Blue California, in addition to other insurance carriers. Dr. Oberlin's hospital/clinic affiliations include Yale Medicine and Yale New Haven Health. His practice in New Haven, CT is open to new patients as reported by Yale New Haven Health.
